Skip to main content

Dr. Sidarth Dasari

Neurology (Neurology Physician)

  • Medicare participating

At a glance

Years since graduation
9
In the NPI registry since
2017
Medicare patients seen, 2024
251

Licensed in Vermont since 2021, according to the Vermont Board of Medical Practice. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2017Medical school: Indiana University School of Medicine
  • 2017Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Neurology Physician primary
    CO license DR.0068451 (first issued 2022; active) · NY license 311231 · VT license 042-0015282 (first issued 2021; lapsed)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Neurology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
251
Services billed
6,031
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes162119
Established patient office or other outpatient visit, 40-54 minutes150109
New patient office or other outpatient visit, 60-74 minutes118118
New patient office or other outpatient visit, 45-59 minutes6161
Established patient office or other outpatient visit, 20-29 minutes4837

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 39 companies reported 313 payments worth $38,684 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$23,230
Food and Beverage$8,600
Consulting Fee$4,675
Travel and Lodging$2,178

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 27, 2025Tg Therapeutics, Inc.
Oct 27, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,673
Jun 2, 2025Tg Therapeutics, Inc.
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,673
Apr 24, 2025Tg Therapeutics, Inc.
Apr 24, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
Aug 20, 2025Tg Therapeutics, Inc.
Aug 20, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
May 19, 2025Tg Therapeutics, Inc.
May 19, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
Apr 14, 2025Tg Therapeutics, Inc.
Apr 14, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
Oct 17, 2025EMD Serono, Inc.
Oct 17, 2025
Consulting Fee
Mavenclad · Neurology
Company’s descriptionAdvisory Board Participation (Fee For Service)
$3,000
Oct 2, 2025Pfizer Inc.
Oct 2, 2025
Consulting Fee
NURTEC ODT · PAIN
$1,525
May 6, 2025Tg Therapeutics, Inc.
May 6, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$1,163
Jun 10, 2025Tg Therapeutics, Inc.
Jun 10, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$1,130
All 22 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Nov 11, 2025Tg Therapeutics, Inc.
Nov 11, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$465
Oct 27, 2025Tg Therapeutics, Inc.
Oct 27, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,673
Oct 27, 2025Tg Therapeutics, Inc.
Oct 27, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Colorado Springs, CO · in-kind
$1,113
Oct 17, 2025EMD Serono, Inc.
Oct 17, 2025
Consulting Fee
Mavenclad · Neurology
Company’s descriptionAdvisory Board Participation (Fee For Service)
$3,000
Oct 2, 2025Pfizer Inc.
Oct 2, 2025
Consulting Fee
NURTEC ODT · PAIN
$1,525
Sep 11, 2025Tg Therapeutics, Inc.
Sep 11, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$233
Aug 20, 2025Tg Therapeutics, Inc.
Aug 20, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
Aug 20, 2025Tg Therapeutics, Inc.
Aug 20, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Greenwood Village, CO
$104
Jun 10, 2025Tg Therapeutics, Inc.
Jun 10, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$1,130
Jun 2, 2025Tg Therapeutics, Inc.
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,673
Jun 2, 2025Tg Therapeutics, Inc.
Jun 2, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Durango, CO
$299
Jun 2, 2025Tg Therapeutics, Inc.
Jun 2, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Durango, CO · in-kind
$279
Jun 2, 2025Tg Therapeutics, Inc.
Jun 2, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Durango, CO
$254
May 28, 2025Biogen, Inc.
May 28, 2025
Consulting Fee
TYSABRI · Neurology
$150
May 19, 2025Tg Therapeutics, Inc.
May 19, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
May 19, 2025Tg Therapeutics, Inc.
May 19, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Lone Tree, CO
$71.40
May 6, 2025Tg Therapeutics, Inc.
May 6, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$1,163
Apr 24, 2025Tg Therapeutics, Inc.
Apr 24, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
Apr 24, 2025Tg Therapeutics, Inc.
Apr 24, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Fort Collins, CO
$40.60
Apr 14, 2025Tg Therapeutics, Inc.
Apr 14, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$3,108
Apr 14, 2025Tg Therapeutics, Inc.
Apr 14, 2025
Travel and Lodging
BRIUMVI · Immunology · travel to Colorado Springs, CO
$17.50
Mar 17, 2025Tg Therapeutics, Inc.
Mar 17, 2025
Compensation for services other than consulting (speaking, faculty)
BRIUMVI · Immunology
$465

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Colorado →

Industry-funded research

Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $264,898 in research payments for these studies, mostly to the institutions running them.

  • (ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study
    Tg Therapeutics, Inc.
  • A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment …
    Novartis Pharmaceuticals Corporation
  • Ocrelizumab RMS High Dose Study
    Genentech, Inc.
  • Ocrelizumab PPMS High Dose Study
    Genentech, Inc.
  • Evaluation of Fenebrutinib in RMS patients
    Genentech, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Neurology clinicians in Boulder

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 3, 2026), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1497286421. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.